Clinical endpoints are necessary in the interim analysis of REGENERATE - Authors' reply
Lancet
.
2020 Sep 5;396(10252):663-664.
doi: 10.1016/S0140-6736(20)30807-2.
Authors
Vlad Ratziu
1
,
Zobair M Younossi
2
,
Jason A Campagna
3
,
Leigh MacConell
3
,
Arun J Sanyal
4
Affiliations
1
Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Institute for Cardiometabolism and Nutrition, Paris, France.
2
Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, USA.
3
Intercept Pharmaceuticals, San Diego, CA, USA.
4
Virginia Commonwealth University, Richmond, VA 23298, USA. Electronic address: arun.sanyal@vcuhealth.org.
PMID:
32891200
DOI:
10.1016/S0140-6736(20)30807-2
No abstract available
Publication types
Letter
Comment